Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 12, 2016

Total Value: $278M (100.0% shares, 0.0% debt)

Holdings (20)

UTHR UNITED THERAPEUTICS CORP 10.5%

Value $29.15M Shares 275,248 Est. Cost $136.10 Unrealized -18.0%

OM2 ORTHOFIX INTERNATIONAL NV 9.9%

Value $27.41M Shares 646,446 Est. Cost $32.01 Unrealized —

— IMPAX LABORATORIES INC 7.6%

Value $21.06M Shares 730,817 Est. Cost $33.19 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 7.2%

Value $20M Shares 906,930 Est. Cost $37.63 Unrealized -30.4%

TEVA TEVA PHARMACEUTICAL-SP ADR 7.2%

Value $19.92M Shares 396,545 Est. Cost $58.35 Unrealized —

— AMGEN INC 6.9%

Value $19.14M Shares 125,802 Est. Cost $152.19 Unrealized —

— HALYARD HEALTH INC 6.7%

Value $18.71M Shares 575,206 Est. Cost $40.74 Unrealized —

— SUCAMPO PHARMACEUTICALS-CL A 6.4%

Value $17.9M Shares 1,631,398 Est. Cost $12.18 Unrealized —

— INDIVIOR PLC 5.7%

Value $15.8M Shares 4,727,970 Est. Cost $3.34 Unrealized —

CNMD CONMED CORP 5.7%

Value $15.71M Shares 329,142 Est. Cost $37.99 Unrealized +0.6%

MRK MERCK & CO. INC. 5.3%

Value $14.84M Shares 257,538 Est. Cost $39.26 Unrealized +0.6%

— RTI SURGICAL INC 4.7%

Value $13.1M Shares 3,648,001 Est. Cost $4.60 Unrealized —

— SHIRE PLC-ADR 4.2%

Value $11.63M Shares 63,166 Est. Cost $184.09 Unrealized —

— INVACARE CORP 3.9%

Value $10.93M Shares 901,440 Est. Cost $14.51 Unrealized —

— ALLERGAN PLC 2.2%

Value $6.104M Shares 26,416 Est. Cost $303.07 Unrealized —

— DEPOMED INC 1.5%

Value $4.275M Shares 217,904 Est. Cost $16.75 Unrealized —

— AVIRAGEN THERAPEUTICS INC 1.4%

Value $3.791M Shares 2,708,438 Est. Cost $1.40 Unrealized —

— DERMA SCIENCES INC 1.3%

Value $3.588M Shares 910,703 Est. Cost $4.57 Unrealized —

— DIGIRAD CORP 0.9%

Value $2.478M Shares 481,218 Est. Cost $4.41 Unrealized —

— JUNIPER PHARMACEUTICALS INC 0.7%

Value $2.017M Shares 287,755 Est. Cost $9.19 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	275,248	$29.15M	10.5%	$136.10	-18.0%	COM	91307C102
OM2	ORTHOFIX INTERNATIONAL NV	646,446	$27.41M	9.9%	$32.01	—	COM	N6748L102
—	IMPAX LABORATORIES INC	730,817	$21.06M	7.6%	$33.19	—	COM	45256B101
ENTA	ENANTA PHARMACEUTICALS INC	906,930	$20M	7.2%	$37.63	-30.4%	COM	29251M106
TEVA	TEVA PHARMACEUTICAL-SP ADR	396,545	$19.92M	7.2%	$58.35	—	COM	881624209
—	AMGEN INC	125,802	$19.14M	6.9%	$152.19	—	COM	31162100
—	HALYARD HEALTH INC	575,206	$18.71M	6.7%	$40.74	—	COM	40650V100
—	SUCAMPO PHARMACEUTICALS-CL A	1,631,398	$17.9M	6.4%	$12.18	—	COM	864909106
—	INDIVIOR PLC	4,727,970	$15.8M	5.7%	$3.34	—	COM	G4766E108
CNMD	CONMED CORP	329,142	$15.71M	5.7%	$37.99	+0.6%	COM	207410101
MRK	MERCK & CO. INC.	257,538	$14.84M	5.3%	$39.26	+0.6%	COM	58933Y105
—	RTI SURGICAL INC	3,648,001	$13.1M	4.7%	$4.60	—	COM	74975N105
—	SHIRE PLC-ADR	63,166	$11.63M	4.2%	$184.09	—	COM	82481R106
—	INVACARE CORP	901,440	$10.93M	3.9%	$14.51	—	COM	461203101
—	ALLERGAN PLC	26,416	$6.104M	2.2%	$303.07	—	COM	G0177J108
—	DEPOMED INC	217,904	$4.275M	1.5%	$16.75	—	COM	249908104
—	AVIRAGEN THERAPEUTICS INC	2,708,438	$3.791M	1.4%	$1.40	—	COM	53761102
—	DERMA SCIENCES INC	910,703	$3.588M	1.3%	$4.57	—	COM	249827502
—	DIGIRAD CORP	481,218	$2.478M	0.9%	$4.41	—	COM	253827109
—	JUNIPER PHARMACEUTICALS INC	287,755	$2.017M	0.7%	$9.19	—	COM	48203L107